Skip to main content

Table 2 Basic clinical and anthropometric characteristics of participants before intervention

From: Suppression of DNA/RNA and protein oxidation by dietary supplement which contains plant extracts and vitamins: a randomized, double-blind, placebo-controlled trial

 

Placebo (N = 28)

Supplement (N = 30)

p

Age (years)

32.9 ± 5.6

34.9 ± 5.8

0.2

Gender, (%male)

64.3

73.3

0.5

Body mass index (kg/m2)

26.6 ± 2.9

26.0 ± 1.9

0.6

Current smokers (%)

75.0

53.3

0.1

Systolic blood pressure (mm Hg)

126.9 ± 10.2

122.7 ± 10.4

0.08

Diastolic blood pressure (mm Hg)

78.5 ± 8.8

74.4 ± 8.5

0.1

WBC (103/μL)

5.7 ± 1.4

6.24 ± 1.3

0.2

RBC (106/μL

4.4 ± 1.4

4.54 ± 1.3

0.7

PLT 103/μL

224.0 ± 59.1

240.64 ± 32.4

0.2

Hb (g/L)

14.6 ± 2.7

15.14 ± 1.3

0.5

Ht (%)

40.9 ± 4.2

40.34 ± 4.0

0.5

Glucose (mmol/L)

5.31 ± 0.56

5.62 ± 0.71

0.08

Cholesterol (mmol/L)

4.85 ± 1.11

5.20 ± 1.09

0.2

HDL-cholesterol (mmol/L)

1.27 ± 0.36

1.19 ± 0.4

0.4

LDL-cholesterol (mmol/L)

3.20 ± 1.13

3.57 ± 1.13

0.2

Triacylglycerols (mmol/L)

0.82 ± 0.44

1.04 ± 0.73

0.2

Uric acid (mmol/L)

0.28 ± 0.07

0.27 ± 0.07

0.6

  1. Data are presented as means ± SD for normally distributed variables or as relative frequencies (%) for categorical variables t-test or chi-square was used for the comparisons respectively